F
Overview
Feanix Biotechnologies offers genetic testing for livestock, especially cattle, using non-invasive samples such as hair or feathers mailed by farmers. The tests determine a calf’s genetic status for various mutations, including Calf Recumbency, by analyzing the sample and reporting whether the animal is healthy, a carrier, or afflicted. Tests are priced starting around $10 per assay, with additional fees for certain sample types, and results are delivered quickly. The company targets cattle breeders and farmers who want faster, affordable genetic information to improve herd health and reduce losses from genetic disorders.
Work here?Claim your company
Simplify's take
What believers are saying
- Feanix raised $5.3M in December 2025 and totals $8.3M, funding execution.
- In September 2026, Feanix moved headquarters to Scotts Valley and opened a wet lab.
- Hiring accelerated in November 2026, with eight open roles and four posted recently.
What critics are saying
- Most differentiation is software orchestration; Zoetis or Alta can bundle similar analytics by 2027.
- Feanix remains tiny, with about five people and a seed-stage balance sheet.
- If farmers distrust black-box recommendations, churn kills the genetics-data flywheel and the company.
What makes Feanix Biotechnologies unique
- Feanix Autopilot prices each cow using genomics, milk checks, feed costs, and economics.
- The platform integrates directly with DairyComp, avoiding new farmer workflows and training overhead.
- Built by farmers, Feanix combines wet lab genetics and software in one product.
Help us improve and share your feedback! Did you find this helpful?
Funding
Notable Investors:
Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Industry standards
Ind Avg. $3.3M
$500k
$1.5M
$2M
$2.3M
$3M
$5.3M